Teacher Retirement System of Texas Reduces Holdings in Astrana Health, Inc. (NASDAQ:ASTH)

Teacher Retirement System of Texas lowered its stake in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 46.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 43,578 shares of the company's stock after selling 37,629 shares during the period. Teacher Retirement System of Texas owned approximately 0.09% of Astrana Health worth $1,351,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of the stock. Quarry LP boosted its stake in Astrana Health by 35.5% in the fourth quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after buying an additional 471 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Astrana Health by 3.9% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,505 shares of the company's stock valued at $773,000 after buying an additional 915 shares in the last quarter. Swiss National Bank boosted its stake in Astrana Health by 1.1% in the fourth quarter. Swiss National Bank now owns 88,444 shares of the company's stock valued at $2,789,000 after buying an additional 1,000 shares in the last quarter. MetLife Investment Management LLC boosted its stake in Astrana Health by 4.7% in the fourth quarter. MetLife Investment Management LLC now owns 26,284 shares of the company's stock valued at $829,000 after buying an additional 1,173 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its stake in Astrana Health by 19.9% in the fourth quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock valued at $225,000 after buying an additional 1,184 shares in the last quarter. Institutional investors own 52.77% of the company's stock.

Astrana Health Trading Down 2.8%

Shares of Astrana Health stock traded down $0.71 during midday trading on Friday, reaching $24.90. The company had a trading volume of 310,514 shares, compared to its average volume of 296,297. The stock has a fifty day moving average price of $25.99 and a 200 day moving average price of $30.41. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.70 and a quick ratio of 1.70. The firm has a market cap of $1.40 billion, a PE ratio of 34.58, a P/E/G ratio of 0.91 and a beta of 0.84. Astrana Health, Inc. has a fifty-two week low of $23.12 and a fifty-two week high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.23 by ($0.09). The firm had revenue of $620.39 million for the quarter, compared to the consensus estimate of $628.11 million. Astrana Health had a net margin of 1.56% and a return on equity of 4.90%. The company's revenue was up 53.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.31 EPS. On average, equities analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on ASTH shares. Truist Financial cut their price target on Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a research note on Tuesday, March 18th. Barclays started coverage on Astrana Health in a research note on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 price target on the stock. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $53.29.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.